Skip to main content
Article

MDR-TB has new drug foe after fast-track approval

JAMA
DOI: 10.1001/jama.2013.94
20Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Voelker, R. (2013, February 6). MDR-TB has new drug foe after fast-track approval. JAMA. American Medical Association. https://doi.org/10.1001/jama.2013.94

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free